A molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients, according to a study published in the journal Cell Genomics.
A molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients, according to a study published in the journal Cell Genomics.
Leave A Comment